Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (Us)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Coronary Vasculature Equipment Supplied In Usa
4 equipment items found
Manufactured by:Reflow Medical, Inc. based inSan Clemente, CALIFORNIA (USA)
Expanded Indication to Cross Chronic Total Occlusions (CTOS) in Peripheral Artery Disease. Compatible with the physician’s choice of guidewire. Works with the Reflow Spex™ and SpexLP™ catheters for added support in lesion ...
Manufactured by:VascuTech Medical, LLC based inOaks, PENNSYLVANIA (USA)
Intravascular Drug Delivery Catheters are intended for the local delivery of various therapeutic and diagnostic agents into the coronary and peripheral vasculature. VascuTech Medical is a leading contract manufacturer of precision drug delivery balloon catheters that utilize atraumatic tips to reduce the risk of vessel ...
Manufactured by:Penumbra, Inc. based inAlameda, CALIFORNIA (USA)
Penumbra’s Indigo Aspiration System can be used to remove emboli and thrombi from vessels of the peripheral arterial and venous systems, and for treatment of pulmonary embolism. A minimally-invasive device, Indigo enables the restoration of blood flow in such cases as acute limb ischemia and venous thrombus. The Indigo System utilizes the Penumbra ENGINE® aspiration source capable of ...
Manufactured by:CeloNova BioSciences, Inc. based inCarlsbad, CALIFORNIA (USA)
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...